Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 249 entries
Sorted by: Best Match Show Resources per page
Emotion regulation in action: Use, selection, and success of emotion regulation in adolescents' daily lives.

International journal of behavioral development

Lennarz HK, Hollenstein T, Lichtwarck-Aschoff A, Kuntsche E, Granic I.
PMID: 30613118
Int J Behav Dev. 2019 Jan;43(1):1-11. doi: 10.1177/0165025418755540. Epub 2018 Feb 05.

Successful emotion regulation (ER) is a central aspect of psychosocial functioning and mental health and is thought to improve and be refined in adolescence. Past research on ER has mainly focused on one-time measurements of habitual ER. Linking regulatory...

Cite
Lennarz HK, Hollenstein T, Lichtwarck-Aschoff A, et al. Emotion regulation in action: Use, selection, and success of emotion regulation in adolescents' daily lives. Int J Behav Dev. 2018;43(1):1-11doi: 10.1177/0165025418755540.
Lennarz, H. K., Hollenstein, T., Lichtwarck-Aschoff, A., Kuntsche, E., & Granic, I. (2019). Emotion regulation in action: Use, selection, and success of emotion regulation in adolescents' daily lives. International journal of behavioral development, 43(1), 1-11. https://doi.org/10.1177/0165025418755540
Lennarz, Hannah K, et al. "Emotion regulation in action: Use, selection, and success of emotion regulation in adolescents' daily lives." International journal of behavioral development vol. 43,1 (2019): 1-11. doi: https://doi.org/10.1177/0165025418755540
Lennarz HK, Hollenstein T, Lichtwarck-Aschoff A, Kuntsche E, Granic I. Emotion regulation in action: Use, selection, and success of emotion regulation in adolescents' daily lives. Int J Behav Dev. 2019 Jan;43(1):1-11. doi: 10.1177/0165025418755540. Epub 2018 Feb 05. PMID: 30613118; PMCID: PMC6305959.
Copy Download .nbib Format: NLM
Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Vojinović T, Medarević D, Vranić E, Potpara Z, Krstić M, Djuriš J, Ibrić S.
PMID: 29991917
Saudi Pharm J. 2018 Jul;26(5):725-732. doi: 10.1016/j.jsps.2018.02.017. Epub 2018 Feb 07.

In this study solid dispersions of carbamazepine in the hydrophilic Kollidon® VA64 polymer, adsorbed onto Neusilin® UFL2 adsorption carrier have been employed to improve carbamazepine dissolution rate. In order to evaluate effects of changing in the proportions of all...

Cite
Vojinović T, Medarević D, Vranić E, et al. Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine. Saudi Pharm J. 2018;26(5):725-732doi: 10.1016/j.jsps.2018.02.017.
Vojinović, T., Medarević, D., Vranić, E., Potpara, Z., Krstić, M., Djuriš, J., & Ibrić, S. (2018). Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 26(5), 725-732. https://doi.org/10.1016/j.jsps.2018.02.017
Vojinović, Tanja, et al. "Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 26,5 (2018): 725-732. doi: https://doi.org/10.1016/j.jsps.2018.02.017
Vojinović T, Medarević D, Vranić E, Potpara Z, Krstić M, Djuriš J, Ibrić S. Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine. Saudi Pharm J. 2018 Jul;26(5):725-732. doi: 10.1016/j.jsps.2018.02.017. Epub 2018 Feb 07. PMID: 29991917; PMCID: PMC6035321.
Copy Download .nbib Format: NLM
Lambda and lambda production in central Pb-Pb collisions at 40, 80, and 158A GeV.

Physical review letters

Anticic T, Baatar B, Barna D, Bartke J, Behler M, Betev L, Białkowska H, Billmeier A, Blume C, Boimska B, Botje M, Bracinik J, Bramm R, Brun R, Buncić P, Cerny V, Christakoglou P, Chvala O, Cramer JG, Csató P, Darmenov N, Dimitrov A, Dinkelaker P, Eckardt V, Filip P, Flierl D, Fodor Z, Foka P, Freund P, Friese V, Gál J, Gaździcki M, Georgopoulos G, Gładysz E, Hegyi S, Höhne C, Kadija K, Karev A, Kolesnikov VI, Kollegger T, Kornas E, Korus R, Kowalski M, Kraus I, Kreps M, van Leeuwen M, Lévai P, Litov L, Makariev M, Malakhov AI, Markert C, Mateev M, Mayes BW, Melkumov GL, Meurer C, Mischke A, Mitrovski M, Molnár J, Mrówczyński S, Pálla G, Panagiotou AD, Panayotov D, Perl K, Petridis A, Pikna M, Pinsky L, Pühlhofer F, Reid JG, Renfordt R, Retyk W, Roland C, Roland G, Rybczyński M, Rybicki A, Sandoval A, Sann H, Schmitz N, Seyboth P, Siklér F, Sitar B, Skrzypczak E, Stefanek G, Stock R, Ströbele H, Susa T, Szentpétery I, Sziklai J, Trainor TA, Varga D, Vassiliou M, Veres GI, Vesztergombi G, Vranić D, Wetzler A, Włodarczyk Z, Yoo IK, Zaranek J, Zimányi J.
PMID: 15323906
Phys Rev Lett. 2004 Jul 09;93(2):022302. doi: 10.1103/PhysRevLett.93.022302. Epub 2004 Jul 09.

Production of Lambda and Antilambda hyperons was measured in central Pb-Pb collisions at 40, 80, and 158A GeV beam energy on a fixed target. Transverse mass spectra and rapidity distributions are given for all three energies. The Lambda/pi ratio...

Cite
Anticic T, Baatar B, Barna D, et al. Lambda and lambda production in central Pb-Pb collisions at 40, 80, and 158A GeV. Phys Rev Lett. 2004;93(2):022302doi: 10.1103/PhysRevLett.93.022302.
Anticic, T., Baatar, B., Barna, D., Bartke, J., Behler, M., Betev, L., Białkowska, H., Billmeier, A., Blume, C., Boimska, B., Botje, M., Bracinik, J., Bramm, R., Brun, R., Buncić, P., Cerny, V., Christakoglou, P., Chvala, O., Cramer, J. G., Csató, P., Darmenov, N., Dimitrov, A., Dinkelaker, P., Eckardt, V., Filip, P., Flierl, D., Fodor, Z., Foka, P., Freund, P., Friese, V., Gál, J., Gaździcki, M., Georgopoulos, G., Gładysz, E., Hegyi, S., Höhne, C., Kadija, K., Karev, A., Kolesnikov, V. I., Kollegger, T., Kornas, E., Korus, R., Kowalski, M., Kraus, I., Kreps, M., van Leeuwen, M., Lévai, P., Litov, L., Makariev, M., Malakhov, A. I., Markert, C., Mateev, M., Mayes, B. W., Melkumov, G. L., Meurer, C., Mischke, A., Mitrovski, M., Molnár, J., Mrówczyński, S., Pálla, G., Panagiotou, A. D., Panayotov, D., Perl, K., Petridis, A., Pikna, M., Pinsky, L., Pühlhofer, F., Reid, J. G., Renfordt, R., Retyk, W., Roland, C., Roland, G., Rybczyński, M., Rybicki, A., Sandoval, A., Sann, H., Schmitz, N., Seyboth, P., Siklér, F., Sitar, B., Skrzypczak, E., Stefanek, G., Stock, R., Ströbele, H., Susa, T., Szentpétery, I., Sziklai, J., Trainor, T. A., Varga, D., Vassiliou, M., Veres, G. I., Vesztergombi, G., Vranić, D., Wetzler, A., Włodarczyk, Z., Yoo, I. K., Zaranek, J., & Zimányi, J. (2004). Lambda and lambda production in central Pb-Pb collisions at 40, 80, and 158A GeV. Physical review letters, 93(2), 022302. https://doi.org/10.1103/PhysRevLett.93.022302
Anticic, T, et al. "Lambda and lambda production in central Pb-Pb collisions at 40, 80, and 158A GeV." Physical review letters vol. 93,2 (2004): 022302. doi: https://doi.org/10.1103/PhysRevLett.93.022302
Anticic T, Baatar B, Barna D, Bartke J, Behler M, Betev L, Białkowska H, Billmeier A, Blume C, Boimska B, Botje M, Bracinik J, Bramm R, Brun R, Buncić P, Cerny V, Christakoglou P, Chvala O, Cramer JG, Csató P, Darmenov N, Dimitrov A, Dinkelaker P, Eckardt V, Filip P, Flierl D, Fodor Z, Foka P, Freund P, Friese V, Gál J, Gaździcki M, Georgopoulos G, Gładysz E, Hegyi S, Höhne C, Kadija K, Karev A, Kolesnikov VI, Kollegger T, Kornas E, Korus R, Kowalski M, Kraus I, Kreps M, van Leeuwen M, Lévai P, Litov L, Makariev M, Malakhov AI, Markert C, Mateev M, Mayes BW, Melkumov GL, Meurer C, Mischke A, Mitrovski M, Molnár J, Mrówczyński S, Pálla G, Panagiotou AD, Panayotov D, Perl K, Petridis A, Pikna M, Pinsky L, Pühlhofer F, Reid JG, Renfordt R, Retyk W, Roland C, Roland G, Rybczyński M, Rybicki A, Sandoval A, Sann H, Schmitz N, Seyboth P, Siklér F, Sitar B, Skrzypczak E, Stefanek G, Stock R, Ströbele H, Susa T, Szentpétery I, Sziklai J, Trainor TA, Varga D, Vassiliou M, Veres GI, Vesztergombi G, Vranić D, Wetzler A, Włodarczyk Z, Yoo IK, Zaranek J, Zimányi J. Lambda and lambda production in central Pb-Pb collisions at 40, 80, and 158A GeV. Phys Rev Lett. 2004 Jul 09;93(2):022302. doi: 10.1103/PhysRevLett.93.022302. Epub 2004 Jul 09. PMID: 15323906.
Copy Download .nbib Format: NLM
Older Adults' Knowledge and Perceptions of Whole Foods as an Exercise Recovery Strategy.

Frontiers in nutrition

Hayes EJ, Granic A, Hurst C, Dismore L, Sayer AA, Stevenson E.
PMID: 34671632
Front Nutr. 2021 Oct 04;8:748882. doi: 10.3389/fnut.2021.748882. eCollection 2021.

Resistance exercise is a widely advocated treatment for improving muscle strength and performance in older adults. Maximizing the benefit of resistance exercise by ensuring optimal recovery is an important aim and studies are now seeking interventions to expedite exercise...

Cite
Hayes EJ, Granic A, Hurst C, et al. Older Adults' Knowledge and Perceptions of Whole Foods as an Exercise Recovery Strategy. Front Nutr. 2021;8:748882doi: 10.3389/fnut.2021.748882.
Hayes, E. J., Granic, A., Hurst, C., Dismore, L., Sayer, A. A., & Stevenson, E. (2021). Older Adults' Knowledge and Perceptions of Whole Foods as an Exercise Recovery Strategy. Frontiers in nutrition, 8748882. https://doi.org/10.3389/fnut.2021.748882
Hayes, Eleanor Jayne, et al. "Older Adults' Knowledge and Perceptions of Whole Foods as an Exercise Recovery Strategy." Frontiers in nutrition vol. 8 (2021): 748882. doi: https://doi.org/10.3389/fnut.2021.748882
Hayes EJ, Granic A, Hurst C, Dismore L, Sayer AA, Stevenson E. Older Adults' Knowledge and Perceptions of Whole Foods as an Exercise Recovery Strategy. Front Nutr. 2021 Oct 04;8:748882. doi: 10.3389/fnut.2021.748882. eCollection 2021. PMID: 34671632; PMCID: PMC8520979.
Copy Download .nbib Format: NLM
Bridge to Heart-Liver Transplantation With a Ventricular Assist Device in the Fontan Circulation.

Circulation. Heart failure

Villa CR, Lorts A, Kasten J, Chin C, Alsaied T, Tiao G, Nathan JD, Peters AL, Misfeldt AM, Vranicar M, Morales DL.
PMID: 34789001
Circ Heart Fail. 2021 Dec;14(12):e008018. doi: 10.1161/CIRCHEARTFAILURE.120.008018. Epub 2021 Nov 18.

No abstract available.

Cite
Villa CR, Lorts A, Kasten J, et al. Bridge to Heart-Liver Transplantation With a Ventricular Assist Device in the Fontan Circulation. Circ Heart Fail. 2021;14(12):e008018doi: 10.1161/CIRCHEARTFAILURE.120.008018.
Villa, C. R., Lorts, A., Kasten, J., Chin, C., Alsaied, T., Tiao, G., Nathan, J. D., Peters, A. L., Misfeldt, A. M., Vranicar, M., & Morales, D. L. (2021). Bridge to Heart-Liver Transplantation With a Ventricular Assist Device in the Fontan Circulation. Circulation. Heart failure, 14(12), e008018. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008018
Villa, Chet R, et al. "Bridge to Heart-Liver Transplantation With a Ventricular Assist Device in the Fontan Circulation." Circulation. Heart failure vol. 14,12 (2021): e008018. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.120.008018
Villa CR, Lorts A, Kasten J, Chin C, Alsaied T, Tiao G, Nathan JD, Peters AL, Misfeldt AM, Vranicar M, Morales DL. Bridge to Heart-Liver Transplantation With a Ventricular Assist Device in the Fontan Circulation. Circ Heart Fail. 2021 Dec;14(12):e008018. doi: 10.1161/CIRCHEARTFAILURE.120.008018. Epub 2021 Nov 18. PMID: 34789001.
Copy Download .nbib Format: NLM
Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time.

Medicina (Kaunas, Lithuania)

Vranić L, Radovan A, Poropat G, Mikolašević I, Milić S.
PMID: 34684094
Medicina (Kaunas). 2021 Oct 03;57(10). doi: 10.3390/medicina57101057.

The COVID-19 pandemic was and still is a global burden with more than 178,000,000 cases reported so far. Although it mainly affects respiratory organs, COVID-19 has many extrapulmonary manifestations, including, among other things, liver injury. Many hypotheses have been...

Cite
Vranić L, Radovan A, Poropat G, et al. Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. Medicina (Kaunas). 2021;57(10)doi: 10.3390/medicina57101057.
Vranić, L., Radovan, A., Poropat, G., Mikolašević, I., & Milić, S. (2021). Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. Medicina (Kaunas, Lithuania), 57(10), . https://doi.org/10.3390/medicina57101057
Vranić, Luka, et al. "Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time." Medicina (Kaunas, Lithuania) vol. 57,10 (2021). doi: https://doi.org/10.3390/medicina57101057
Vranić L, Radovan A, Poropat G, Mikolašević I, Milić S. Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. Medicina (Kaunas). 2021 Oct 03;57(10). doi: 10.3390/medicina57101057. PMID: 34684094; PMCID: PMC8540462.
Copy Download .nbib Format: NLM
Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions.

Pharmaceutics

Rahić O, Tucak A, Omerović N, Sirbubalo M, Hindija L, Hadžiabdić J, Vranić E.
PMID: 33375224
Pharmaceutics. 2020 Dec 26;13(1). doi: 10.3390/pharmaceutics13010028.

Glaucoma is considered to be one of the biggest health problems in the world. It is the main cause of preventable blindness due to its asymptomatic nature in the early stages on the one hand and patients' non-adherence on...

Cite
Rahić O, Tucak A, Omerović N, et al. Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions. Pharmaceutics. 2020;13(1)doi: 10.3390/pharmaceutics13010028.
Rahić, O., Tucak, A., Omerović, N., Sirbubalo, M., Hindija, L., Hadžiabdić, J., & Vranić, E. (2020). Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions. Pharmaceutics, 13(1), . https://doi.org/10.3390/pharmaceutics13010028
Rahić, Ognjenka, et al. "Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions." Pharmaceutics vol. 13,1 (2020). doi: https://doi.org/10.3390/pharmaceutics13010028
Rahić O, Tucak A, Omerović N, Sirbubalo M, Hindija L, Hadžiabdić J, Vranić E. Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions. Pharmaceutics. 2020 Dec 26;13(1). doi: 10.3390/pharmaceutics13010028. PMID: 33375224; PMCID: PMC7824381.
Copy Download .nbib Format: NLM
Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent.

The neuroradiology journal

Vranic JE, Harker P, Stapleton CJ, Regenhardt RW, Dmytriw AA, Alotaibi NM, Gupta R, Leslie-Mazwi TM, Koch MJ, Raymond SB, Mascitelli JR, Patterson TT, Seinfeld J, White A, Case D, Roark C, Gandhi CD, Al-Mufti F, Cooper J, Patel AB.
PMID: 34747246
Neuroradiol J. 2021 Nov 07;19714009211049086. doi: 10.1177/19714009211049086. Epub 2021 Nov 07.

PURPOSE: Flow diverting stents have revolutionized the treatment of intracranial aneurysms through endoluminal reconstruction of the parent vessel. Despite this, certain aneurysms require retreatment. The purpose of this study was to identify clinical and radiologic determinants of aneurysm retreatment...

Cite
Vranic JE, Harker P, Stapleton CJ, et al. Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent. Neuroradiol J. 2021;19714009211049086doi: 10.1177/19714009211049086.
Vranic, J. E., Harker, P., Stapleton, C. J., Regenhardt, R. W., Dmytriw, A. A., Alotaibi, N. M., Gupta, R., Leslie-Mazwi, T. M., Koch, M. J., Raymond, S. B., Mascitelli, J. R., Patterson, T. T., Seinfeld, J., White, A., Case, D., Roark, C., Gandhi, C. D., Al-Mufti, F., Cooper, J., & Patel, A. B. (2021). Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent. The neuroradiology journal, 19714009211049086. https://doi.org/10.1177/19714009211049086
Vranic, Justin E, et al. "Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent." The neuroradiology journal vol. (2021): 19714009211049086. doi: https://doi.org/10.1177/19714009211049086
Vranic JE, Harker P, Stapleton CJ, Regenhardt RW, Dmytriw AA, Alotaibi NM, Gupta R, Leslie-Mazwi TM, Koch MJ, Raymond SB, Mascitelli JR, Patterson TT, Seinfeld J, White A, Case D, Roark C, Gandhi CD, Al-Mufti F, Cooper J, Patel AB. Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent. Neuroradiol J. 2021 Nov 07;19714009211049086. doi: 10.1177/19714009211049086. Epub 2021 Nov 07. PMID: 34747246.
Copy Download .nbib Format: NLM
Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness.

Cancer cell international

Bonfil RD, Chen W, Vranic S, Sohail A, Shi D, Jang H, Kim HR, Prunotto M, Fridman R.
PMID: 34548097
Cancer Cell Int. 2021 Sep 21;21(1):507. doi: 10.1186/s12935-021-02206-1.

BACKGROUND: The Discoidin Domain Receptor 1 (DDR1) is one of the two members of a unique family of receptor tyrosine kinase receptors that signal in response to collagen, which has been implicated in cancer progression. Here, we examined the...

Cite
Bonfil RD, Chen W, Vranic S, et al. Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness. Cancer Cell Int. 2021;21(1):507doi: 10.1186/s12935-021-02206-1.
Bonfil, R. D., Chen, W., Vranic, S., Sohail, A., Shi, D., Jang, H., Kim, H. R., Prunotto, M., & Fridman, R. (2021). Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness. Cancer cell international, 21(1), 507. https://doi.org/10.1186/s12935-021-02206-1
Bonfil, R Daniel, et al. "Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness." Cancer cell international vol. 21,1 (2021): 507. doi: https://doi.org/10.1186/s12935-021-02206-1
Bonfil RD, Chen W, Vranic S, Sohail A, Shi D, Jang H, Kim HR, Prunotto M, Fridman R. Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness. Cancer Cell Int. 2021 Sep 21;21(1):507. doi: 10.1186/s12935-021-02206-1. PMID: 34548097; PMCID: PMC8456559.
Copy Download .nbib Format: NLM
High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions.

Frontiers in oncology

Allouch S, Malki A, Allouch A, Gupta I, Vranic S, Al Moustafa AE.
PMID: 32695664
Front Oncol. 2020 Jun 30;10:914. doi: 10.3389/fonc.2020.00914. eCollection 2020.

Cervical cancer is the fourth most common malignancy in women worldwide and a leading cause of cancer-related mortality in developing countries. Important etiological factors in this cancer are high-risk human papillomaviruses (HPV), as roughly 96% of cervical cancer cases...

Cite
Allouch S, Malki A, Allouch A, et al. High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions. Front Oncol. 2020;10:914doi: 10.3389/fonc.2020.00914.
Allouch, S., Malki, A., Allouch, A., Gupta, I., Vranic, S., & Al Moustafa, A. E. (2020). High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions. Frontiers in oncology, 10914. https://doi.org/10.3389/fonc.2020.00914
Allouch, Soumaya, et al. "High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions." Frontiers in oncology vol. 10 (2020): 914. doi: https://doi.org/10.3389/fonc.2020.00914
Allouch S, Malki A, Allouch A, Gupta I, Vranic S, Al Moustafa AE. High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions. Front Oncol. 2020 Jun 30;10:914. doi: 10.3389/fonc.2020.00914. eCollection 2020. PMID: 32695664; PMCID: PMC7338567.
Copy Download .nbib Format: NLM
Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and Prognosis.

Toxics

López-Ozuna VM, Gupta I, Kiow RLC, Matanes E, Kheraldine H, Yasmeen A, Khalil A, Vranic S, Al Moustafa AE, Farsi HFA.
PMID: 32961854
Toxics. 2020 Sep 18;8(3). doi: 10.3390/toxics8030073.

Water-pipe smoking (WPS) is becoming the most popular form of tobacco use among the youth, especially in the Middle East, replacing cigarettes rapidly and becoming a major risk of tobacco addiction worldwide. Smoke from WPS contains similar toxins as...

Cite
López-Ozuna VM, Gupta I, Kiow RLC, et al. Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and Prognosis. Toxics. 2020;8(3)doi: 10.3390/toxics8030073.
López-Ozuna, V. M., Gupta, I., Kiow, R. L. C., Matanes, E., Kheraldine, H., Yasmeen, A., Khalil, A., Vranic, S., Al Moustafa, A. E., & Farsi, H. F. A. (2020). Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and Prognosis. Toxics, 8(3), . https://doi.org/10.3390/toxics8030073
López-Ozuna, Vanessa M, et al. "Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and Prognosis." Toxics vol. 8,3 (2020). doi: https://doi.org/10.3390/toxics8030073
López-Ozuna VM, Gupta I, Kiow RLC, Matanes E, Kheraldine H, Yasmeen A, Khalil A, Vranic S, Al Moustafa AE, Farsi HFA. Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and Prognosis. Toxics. 2020 Sep 18;8(3). doi: 10.3390/toxics8030073. PMID: 32961854; PMCID: PMC7560251.
Copy Download .nbib Format: NLM
PD-L1 status in breast cancer: Current view and perspectives.

Seminars in cancer biology

Vranic S, Cyprian FS, Gatalica Z, Palazzo J.
PMID: 31883913
Semin Cancer Biol. 2021 Jul;72:146-154. doi: 10.1016/j.semcancer.2019.12.003. Epub 2019 Dec 26.

Breast cancer was traditionally not considered a particularly immunogenic tumor. However, recent developments have shown that some aggressive triple-negative breast cancers are immunogenic, exhibit a resistance to chemotherapy and have a poor prognosis. These cancers have been shown to...

Cite
Vranic S, Cyprian FS, Gatalica Z, et al. PD-L1 status in breast cancer: Current view and perspectives. Semin Cancer Biol. 2019;72:146-154doi: 10.1016/j.semcancer.2019.12.003.
Vranic, S., Cyprian, F. S., Gatalica, Z., & Palazzo, J. (2021). PD-L1 status in breast cancer: Current view and perspectives. Seminars in cancer biology, 72146-154. https://doi.org/10.1016/j.semcancer.2019.12.003
Vranic, Semir, et al. "PD-L1 status in breast cancer: Current view and perspectives." Seminars in cancer biology vol. 72 (2021): 146-154. doi: https://doi.org/10.1016/j.semcancer.2019.12.003
Vranic S, Cyprian FS, Gatalica Z, Palazzo J. PD-L1 status in breast cancer: Current view and perspectives. Semin Cancer Biol. 2021 Jul;72:146-154. doi: 10.1016/j.semcancer.2019.12.003. Epub 2019 Dec 26. PMID: 31883913.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 249 entries